{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:07:38Z","timestamp":1791119258802,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2486,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.bbadis.2006.04.005","type":"journal-article","created":{"date-parts":[[2006,5,10]],"date-time":"2006-05-10T15:16:05Z","timestamp":1147274165000},"page":"1109-1121","source":"Crossref","is-referenced-by-count":91,"title":["VEGF at the neurovascular interface: Therapeutic implications for motor neuron disease"],"prefix":"10.1016","volume":"1762","author":[{"given":"Diether","family":"Lambrechts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Carmeliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2006.04.005_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nature03875","article-title":"Common mechanisms of nerve and blood vessel wiring","volume":"436","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.04.005_bib2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrg1158","article-title":"Blood vessels and nerves: common signals, pathways and diseases","volume":"4","author":"Carmeliet","year":"2003","journal-title":"Nat. Rev., Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/aja.1002040303","article-title":"Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development","volume":"204","author":"Breier","year":"1995","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bbadis.2006.04.005_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/aja.1002030109","article-title":"Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development","volume":"203","author":"Dumont","year":"1995","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bbadis.2006.04.005_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2006.04.005_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1172\/JCI0214362","article-title":"Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms","volume":"109","author":"Stalmans","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2006.04.005_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.04.005_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/380439a0","article-title":"Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene","volume":"380","author":"Ferrara","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.04.005_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/8379","article-title":"Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188","volume":"5","author":"Carmeliet","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2006.04.005_bib10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/01.ASN.0000013925.19218.7B","article-title":"Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice","volume":"13","author":"Mattot","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0925-4773(01)00601-3","article-title":"Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188","volume":"111","author":"Maes","year":"2002","journal-title":"Mech. Dev."},{"key":"10.1016\/j.bbadis.2006.04.005_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbadis.2006.04.005_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev., Drug Discov."},{"key":"10.1016\/j.bbadis.2006.04.005_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1242\/dev.114.2.521","article-title":"Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation","volume":"114","author":"Breier","year":"1992","journal-title":"Development"},{"key":"10.1016\/j.bbadis.2006.04.005_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(93)90573-9","article-title":"High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis","volume":"72","author":"Millauer","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2006.04.005_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-3806(99)00125-X","article-title":"Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain","volume":"119","author":"Ogunshola","year":"2000","journal-title":"Brain Res.. Dev. Brain Res.."},{"key":"10.1016\/j.bbadis.2006.04.005_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0012-1606(03)00356-7","article-title":"Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling","volume":"262","author":"Haigh","year":"2003","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1160\/TH03-09-0582","article-title":"Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor","volume":"91","author":"Raab","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2006.04.005_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/brain\/awh325","article-title":"VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena","volume":"128","author":"Wang","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2006.04.005_bib20","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1101\/gad.242002","article-title":"Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis","volume":"16","author":"Ruhrberg","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2006.04.005_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(02)00757-2","article-title":"Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin","volume":"109","author":"Mukouyama","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2006.04.005_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0012-1606(02)00045-3","article-title":"Neurovascular congruence results from a shared patterning mechanism that utilizes semaphorin3A and neuropilin-1","volume":"255","author":"Bates","year":"2003","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib23","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1096\/fj.04-2320fje","article-title":"VEGF is required for the maintenance of dorsal root ganglia blood vessels but not neurons during development","volume":"18","author":"Kutcher","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2006.04.005_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1242\/dev.01675","article-title":"Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback","volume":"132","author":"Mukouyama","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.bbadis.2006.04.005_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.12.047","article-title":"The neuropilins and their role in tumorigenesis and tumor progression","volume":"231","author":"Guttmann-Raviv","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2006.04.005_bib26","doi-asserted-by":"crossref","first-page":"18069","DOI":"10.1074\/jbc.M201681200","article-title":"Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165","volume":"277","author":"Gu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2006.04.005_bib27","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1073\/pnas.162366299","article-title":"Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2006.04.005_bib28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0896-6273(00)80392-X","article-title":"Neuropilin-semaphorin III\/D-mediated chemorepulsive signals play a crucial role in peripheral nerve\u00a0projection in mice","volume":"19","author":"Kitsukawa","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2006.04.005_bib29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0092-8674(00)80535-8","article-title":"Neuropilin is a semaphorin III receptor","volume":"90","author":"Kolodkin","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2006.04.005_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0896-6273(00)80869-7","article-title":"Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins","volume":"25","author":"Giger","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2006.04.005_bib31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0092-8674(00)80534-6","article-title":"Neuropilin is a receptor for the axonal chemorepellent semaphorin III","volume":"90","author":"He","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2006.04.005_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0092-8674(00)80062-8","article-title":"Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors","volume":"99","author":"Takahashi","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2006.04.005_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0896-6273(01)00216-1","article-title":"Plexina1 autoinhibition by the plexin sema domain","volume":"29","author":"Takahashi","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2006.04.005_bib34","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1242\/dev.126.21.4895","article-title":"A requirement for neuropilin-1 in embryonic vessel formation","volume":"126","author":"Kawasaki","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.bbadis.2006.04.005_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1534-5807(03)00169-2","article-title":"Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development","volume":"5","author":"Gu","year":"2003","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbadis.2006.04.005_bib36","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1101\/gad.322904","article-title":"Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve","volume":"18","author":"Schwarz","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2006.04.005_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/dvdy.20520","article-title":"Neuropilin-1a is involved in trunk motor axon outgrowth in embryonic zebrafish","volume":"234","author":"Feldner","year":"2005","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bbadis.2006.04.005_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0304-3940(02)00595-5","article-title":"Caenorhabditis elegans receptors related to mammalian vascular endothelial growth factor receptors are expressed in neural cells","volume":"329","author":"Popovici","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2006.04.005_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00502-5","article-title":"Guidance of cell migration by the Drosophila PDGF\/VEGF receptor","volume":"107","author":"Duchek","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2006.04.005_bib40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0092-8674(02)00676-1","article-title":"Developmental control of blood cell migration by the Drosophila VEGF pathway","volume":"108","author":"Cho","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2006.04.005_bib41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bies.20092","article-title":"VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection","volume":"26","author":"Storkebaum","year":"2004","journal-title":"BioEssays"},{"key":"10.1016\/j.bbadis.2006.04.005_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmed.2003.11.006","article-title":"VEGF and ALS: the luckiest growth factor?","volume":"10","author":"Greenberg","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2006.04.005_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jnr.20321","article-title":"Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor","volume":"79","author":"Sun","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2006.04.005_bib44","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nature04481","article-title":"From angiogenesis to neuropathology","volume":"438","author":"Greenberg","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.04.005_bib45","doi-asserted-by":"crossref","first-page":"11036","DOI":"10.1523\/JNEUROSCI.23-35-11036.2003","article-title":"Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons","volume":"23","author":"Rosenstein","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2006.04.005_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2004.06.004","article-title":"Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration","volume":"17","author":"Van Den Bosch","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2006.04.005_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2004.12.031","article-title":"Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia","volume":"132","author":"Shiote","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2006.04.005_bib49","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0306-4522(98)00540-5","article-title":"Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures","volume":"90","author":"Silverman","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2006.04.005_bib50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00615-7","article-title":"Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain","volume":"110","author":"Krum","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2006.04.005_bib51","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/01.WCB.0000090620.86921.9C","article-title":"Activation of receptor-mediated angiogenesis and signaling pathways after VEGF administration in fetal rat CNS explants","volume":"23","author":"Mani","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbadis.2006.04.005_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-5728(02)00315-6","article-title":"Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells","volume":"132","author":"Forstreuter","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib53","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1523\/JNEUROSCI.19-14-05731.1999","article-title":"Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system","volume":"19","author":"Sondell","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2006.04.005_bib54","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/74664","article-title":"Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy","volume":"6","author":"Schratzberger","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2006.04.005_bib55","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1523\/JNEUROSCI.21-10-03332.2001","article-title":"Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor","volume":"21","author":"Bagnard","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2006.04.005_bib56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1750-3639.2004.tb00060.x","article-title":"Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor","volume":"14","author":"Schanzer","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib57","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng1395","article-title":"VEGF links hippocampal activity with neurogenesis, learning and memory","volume":"36","author":"Cao","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib58","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N. Engl. J.Med."},{"key":"10.1016\/j.bbadis.2006.04.005_bib59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmed.2004.06.009","article-title":"Lessons from models of SOD1-linked familial ALS","volume":"10","author":"Bendotti","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2006.04.005_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-2001-15260","article-title":"Amyotrophic lateral sclerosis: pathogenesis","volume":"21","author":"Brown","year":"2001","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib61","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","article-title":"Unraveling the mechanisms involved in motor neuron degeneration in ALS","volume":"27","author":"Bruijn","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2006.04.005_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11910-001-0078-7","article-title":"Progress in the pathogenesis of amyotrophic lateral sclerosis","volume":"1","author":"Shaw","year":"2001","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bbadis.2006.04.005_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.0009-9163.2002.00001.x","article-title":"Genetic epidemiology of amyotrophic lateral sclerosis","volume":"63","author":"Majoor-Krakauer","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.04.005_bib65","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0896-6273(00)81108-3","article-title":"From Charcot to SOD1: mechanisms of selective motor neuron death in ALS","volume":"24","author":"Cleveland","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2006.04.005_bib66","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2006.04.005_bib67","doi-asserted-by":"crossref","first-page":"9246","DOI":"10.1523\/JNEUROSCI.21-23-09246.2001","article-title":"Rats expressing human cytosolic copper\u2013zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease","volume":"21","author":"Nagai","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2006.04.005_bib68","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/425287","article-title":"A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis","volume":"75","author":"Nishimura","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib69","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ng1001-160","article-title":"The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis","volume":"29","author":"Yang","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib70","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/archneur.60.12.1768","article-title":"Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis","volume":"60","author":"Hand","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib71","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/421054","article-title":"DNA\/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)","volume":"74","author":"Chen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib72","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.molmed.2004.04.004","article-title":"VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?","volume":"10","author":"Lambrechts","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2006.04.005_bib73","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1097\/00001756-200411150-00016","article-title":"Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats","volume":"15","author":"Xie","year":"2004","journal-title":"NeuroReport"},{"key":"10.1016\/j.bbadis.2006.04.005_bib74","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1212\/01.WNL.0000129913.44351.A3","article-title":"Low levels of the vascular endothelial growth factor in CSF from early ALS patients","volume":"62","author":"Devos","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2006.04.005_bib75","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/01677060490894450","article-title":"VEGF promoter haplotype and amyotrophic lateral sclerosis (ALS)","volume":"18","author":"Terry","year":"2004","journal-title":"J. Neurogenet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib76","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1212\/01.wnl.0000184514.39853.56","article-title":"Lack of association between VEGF polymorphisms and ALS in a Dutch population","volume":"65","author":"Van Vught","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2006.04.005_bib77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10048-004-0201-4","article-title":"Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis","volume":"6","author":"Brockington","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.bbadis.2006.04.005_bib78","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1071","article-title":"Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease","volume":"33","author":"Lohmueller","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jnnp.2005.070904","article-title":"Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS","volume":"77","author":"Moreau","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbadis.2006.04.005_bib80","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jnen.0000196134.51217.74","article-title":"Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis","volume":"65","author":"Brockington","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib81","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nn1360","article-title":"Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS","volume":"8","author":"Storkebaum","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2006.04.005_bib82","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0896-6273(04)00082-0","article-title":"Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration","volume":"41","author":"Sopher","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2006.04.005_bib83","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1212\/01.WNL.0000144344.39103.F6","article-title":"A novel candidate region for ALS on chromosome 14q11.2","volume":"63","author":"Greenway","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2006.04.005_bib84","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ng1742","article-title":"ANG mutations segregate with familial and \u2018sporadic\u2019 amyotrophic lateral sclerosis","volume":"38","author":"Greenway","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib85","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1009015512200","article-title":"The angiogenins: an emerging family ofribonuclease related proteins with diverse cellular functions","volume":"3","author":"Adams","year":"1999","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bbadis.2006.04.005_bib86","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.onc.1208223","article-title":"Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis","volume":"24","author":"Kishimoto","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2006.04.005_bib87","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ni888","article-title":"Angiogenins: a new class of microbicidal proteins involved in innate immunity","volume":"4","author":"Hooper","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib88","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1158\/0008-5472.CAN-04-2058","article-title":"Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation","volume":"65","author":"Tsuji","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2006.04.005_bib89","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J.Med."},{"issue":"Suppl 1","key":"10.1016\/j.bbadis.2006.04.005_bib90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/17434470410019942","article-title":"Randomized control trials in ALS: lessons learned","volume":"5","author":"Mitsumoto","year":"2004","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"10.1016\/j.bbadis.2006.04.005_bib91","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nn938","article-title":"Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches","volume":"5","author":"Thoenen","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2006.04.005_bib92","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0166-2236(00)01899-3","article-title":"Recombinant proteins for neurodegenerative diseases: the delivery issue","volume":"24","author":"Aebischer","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2006.04.005_bib93","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.51.2.583","article-title":"A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS\/IGF-I Study Group","volume":"51","author":"Borasio","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2006.04.005_bib94","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.49.6.1621","article-title":"Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS\/IGF-I Study Group","volume":"49","author":"Lai","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2006.04.005_bib95","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1043-4666(03)00217-5","article-title":"The effect of leukaemia inhibitory factor on SOD1 G93A murine amyotrophic lateral sclerosis","volume":"23","author":"Feeney","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.bbadis.2006.04.005_bib96","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0006-8993(03)02989-5","article-title":"Behavioural and anatomical effects of systemically administered leukemia inhibitory factor in the SOD1(G93A G1H) mouse model of familial amyotrophic lateral sclerosis","volume":"982","author":"Azari","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2006.04.005_bib97","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations","volume":"40","author":"Thorne","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib98","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2006.04.005_bib99","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","article-title":"VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model","volume":"429","author":"Azzouz","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.04.005_bib100","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/10.19.2109","article-title":"Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery","volume":"10","author":"Mazarakis","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib101","first-page":"95","article-title":"The pathogenesis of rabies and other lyssaviral infections: recent studies","volume":"187","author":"Charlton","year":"1994","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib102","doi-asserted-by":"crossref","unstructured":"M. Azzouz, Gene therapy for ALS: progress and prospects, Biochim. Biophys. Acta (in press). doi:10.1016\/j.bbadis.2006.05.003.","DOI":"10.1016\/j.bbadis.2006.05.003"},{"key":"10.1016\/j.bbadis.2006.04.005_bib103","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.20223","article-title":"Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS","volume":"56","author":"Zheng","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib104","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1179\/016164105X49418","article-title":"Effects of VEGF and nitric oxide synthase inhibition on blood\u2013brain barrier disruption in the ischemic and non-ischemic cerebral cortex","volume":"27","author":"Chi","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bbadis.2006.04.005_bib105","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/sj.jcbfm.9600148","article-title":"VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1","volume":"25","author":"Valable","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbadis.2006.04.005_bib106","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI9369","article-title":"VEGF enhances angiogenesis and promotes blood\u2013brain barrier leakage in the ischemic brain","volume":"106","author":"Zhang","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2006.04.005_bib107","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1172\/JCI8218","article-title":"VEGF antagonism reduces edema formation and tissue damage after ischemia\/reperfusion injury in the mouse brain","volume":"104","author":"van Bruggen","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2006.04.005_bib108","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1023\/A:1026013106016","article-title":"VEGF165 therapy exacerbates secondary damage following spinal cord injury","volume":"28","author":"Benton","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2006.04.005_bib109","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/01.STR.27.10.1865","article-title":"VEGF and flt. Expression time kinetics in rat brain infarct","volume":"27","author":"Kovacs","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.bbadis.2006.04.005_bib110","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1161\/01.STR.28.10.2039","article-title":"Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats","volume":"28","author":"Hayashi","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.bbadis.2006.04.005_bib111","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00005072-199809000-00009","article-title":"Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat","volume":"57","author":"Lennmyr","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib112","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00005072-199906000-00010","article-title":"Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct","volume":"58","author":"Plate","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib113","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI200317977","article-title":"VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia","volume":"111","author":"Sun","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2006.04.005_bib114","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3171\/jns.2005.103.1.0104","article-title":"Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia","volume":"103","author":"Yano","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.bbadis.2006.04.005_bib115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng1211","article-title":"VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death","volume":"34","author":"Lambrechts","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2006.04.005_bib116","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0306-4522(03)00399-3","article-title":"Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury","volume":"120","author":"Widenfalk","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2006.04.005_bib117","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/01.WCB.0000134477.38980.38","article-title":"Increased severity of cerebral ischemic injury in vascular endothelial growth factor-B-deficient mice","volume":"24","author":"Sun","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbadis.2006.04.005_bib118","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ydbio.2005.10.016","article-title":"Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration","volume":"289","author":"Sun","year":"2005","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib119","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4757-6376-8_4","article-title":"Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword","volume":"548","author":"Croll","year":"2004","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib120","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1096\/fj.00-0495fje","article-title":"Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades","volume":"15","author":"Matsuzaki","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2006.04.005_bib121","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1523\/JNEUROSCI.2577-05.2005","article-title":"Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures","volume":"25","author":"McCloskey","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2006.04.005_bib122","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI12188","article-title":"Reversal of experimental diabetic neuropathy by VEGF gene transfer","volume":"107","author":"Schratzberger","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2006.04.005_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/sj.gt.3302533","article-title":"HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy","author":"Chattopadhyay","year":"2005","journal-title":"Gene Ther."},{"issue":"Pt 4","key":"10.1016\/j.bbadis.2006.04.005_bib124","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1469-7580.2000.19740591.x","article-title":"VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy","volume":"197","author":"Hobson","year":"2000","journal-title":"J.Anat."},{"issue":"Suppl 2","key":"10.1016\/j.bbadis.2006.04.005_bib125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000049150","article-title":"Small vessel disease and Alzheimer's dementia: pathological considerations","volume":"13","author":"Kalaria","year":"2002","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.bbadis.2006.04.005_bib126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0197-4580(03)00111-8","article-title":"Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease","volume":"25","author":"Yang","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2006.04.005_bib127","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","article-title":"Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline","volume":"62","author":"Thal","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.20390","article-title":"Vascular endothelial growth factor gene variability is associated with increased risk for AD","volume":"57","author":"Del Bo","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2006.04.005_bib129","article-title":"Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease","author":"Chapuis","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2006.04.005_bib130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0197-4580(01)00285-8","article-title":"Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia","volume":"23","author":"Tarkowski","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2006.04.005_bib131","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0169-328X(98)00190-9","article-title":"Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia","volume":"62","author":"Kalaria","year":"1998","journal-title":"Brain Res. Mol Brain Res."},{"key":"10.1016\/j.bbadis.2006.04.005_bib132","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.05.027","article-title":"Neurorescue effects of VEGF on a rat model of Parkinson's disease","volume":"1053","author":"Yasuhara","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2006.04.005_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2004.12.055","article-title":"The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model","volume":"1038","author":"Yasuhara","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2006.04.005_bib134","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0014-4886(03)00100-6","article-title":"Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells","volume":"182","author":"Pitzer","year":"2003","journal-title":"Exp. Neurol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443906000792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443906000792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T02:19:02Z","timestamp":1627352342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443906000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":134,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0925443906000792"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2006.04.005","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}